A new device for measuring blood biomarkers at home
Official title: Whole Blood Point of Care Metabolic Measurement
Funded at Sequitur Health Corp. · NIH-10909646 · Data updated 2026-11-12
This study is working on a new device that can quickly and easily check for important health markers in whole blood, which could really help babies and people with rare metabolic disorders get the care they need right at home or in a doctor's office.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sequitur Health Corp. NIH-funded |
| Lab location | 1 site (Scottsdale, United States) |
| Project start | September 17, 2021 |
| Project end | August 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $196,280 |
| NIH project number | 3R44HD107897-03S1 |
| Project ID | NIH-10909646 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with rare metabolic disorders and newborns who are being screened for these conditions.
✕Less likely to help
Patients with common metabolic disorders or those who do not have access to the necessary technology may not benefit from this research.
What this research studies
This research focuses on developing a point of care technology that allows for the direct measurement of specific biomarkers in whole blood without the need for separating plasma. By utilizing advanced sensor materials, the device aims to provide accurate and immediate results, which can significantly enhance the management of rare metabolic disorders. The project will culminate in a draft application for FDA clearance, paving the way for its use in clinical settings and at home. This innovation is particularly important for newborn screening and for individuals managing these rare conditions.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and convenient monitoring of metabolic disorders, improving patient outcomes and management.
How similar studies have gone: Previous research has shown promise in developing point of care devices for various health conditions, indicating potential success for this novel approach.
Where this research is happening
-
Sequitur Health Corp.
Scottsdale, United States Active
Researchers
- Principal investigator: Thomas, Marylaura Lind — Sequitur Health Corp.
- Study coordinator: Thomas, Marylaura Lind
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.